Actively Recruiting
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
Led by University Hospital, Akershus · Updated on 2025-12-12
1000
Participants Needed
1
Research Sites
531 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Akershus
Lead Sponsor
H
Haukeland University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
A considerable proportion of patients with clinically suspected coronary artery disease (CAD) do not have angiographic signs of luminal narrowing caused by coronary atherosclerosis. In patients with suspected CAD, we will assess the ability of cardiovascular biomarkers to identify patients with (a) angiographically normal epicardial coronary vessels (b) absence of significant epicardial coronary stenosis, as assessed by coronary computed tomography angiography (CCTA). Patients will be stratified according to the presence or absence of dynamic changes of high sensitivity cardiac troponin T levels above the 99th percentile.
CONDITIONS
Official Title
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consenting patient over the age of 18 referred to CCTA for suspected coronary artery disease
You will not qualify if you...
- Inability to provide informed consent.
- Short life expectancy (<12 months) due to non-cardiovascular disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Akershus University Hospital
Lørenskog, Norway
Actively Recruiting
Research Team
T
Torbjørn Omland, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here